Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors.
Berkenboom
G
G
Cardiology Department, Erasme Hospital, Brussels, Belgium.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001920:Bradykinin / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D009569:Nitric Oxide / Q000378:metabolism; D017257:Ramipril / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014664:Vasodilation / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D009569:Nitric Oxide; C052549:ramiprilat; C065679:icatibant; D017257:Ramipril; D001920:Bradykinin